Back to All Events

Hep B and Hep D Drug Development: From Molecule to Medicine @8AM HST

This webinar will provide an overview of the clinical trial process, current HBV and HDV therapies, and an introduction to interpreting clinical trial data. This webinar is part ONE of a two-part series intended for patients, advocates, and other stakeholders who are interested in learning more about the clinical trial process for HBV and HDV. The webinar is co-hosted by the Hepatitis B Foundation and the National Viral Hepatitis Roundtable (NVHR).

Previous
Previous
October 3

Hawaiʻi Hep B ECHO (CME, CPE, CE) @12PM HST

Next
Next
October 6

Fundamentals of Perinatal Harm Reduction, Part 3 @12PM HST